microRNAs in Psoriasis

Journal of Investigative Dermatology

Volumn 136, Issue 2, 2016, Pages 365-371

  Hawkes, Jason E ^a   Nguyen, Giang Huong ^b   Fujita, Mayumi ^b   Florell, Scott R ^a   Callis Duffin, Kristina ^a   Krueger, Gerald G ^a   O'Connell, Ryan M ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 17; MESSENGER RNA; MICRORNA; MICRORNA 125B; MICRORNA 143; MICRORNA 146A; MICRORNA 184; MICRORNA 203; MICRORNA 21; MICRORNA 210; MICRORNA 221; MICRORNA 222; MICRORNA 223; MICRORNA 31; MICRORNA 424; MICRORNA 99A; RNA INDUCED SILENCING COMPLEX; STAT3 PROTEIN; UNCLASSIFIED DRUG;

CHRONIC INFLAMMATION; DISEASE PREDISPOSITION; GENE LOCUS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PSORIASIS; REVIEW; RNA DEGRADATION; SYSTEMIC THERAPY; TRANSCRIPTION REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; MALE; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY;

FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRORNAS; PSORIASIS; SENSITIVITY AND SPECIFICITY;

EID: 84973442772     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/JID.2015.409     Document Type: Review

References (86)

1. Bergboer, J.G., Zeeuwen, P.L., Schalkwijk, J., Genetics of psoriasis: evidence for epistatic interaction between skin barrier abnormalities and immune deviation. J Invest Dermatol 132 (2012), 2320–2331.
2. Boele, J., Persson, H., Shin, J.W., et al. PAPD5-mediated 3′ adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease. Proc Natl Acad Sci USA 111 (2014), 11467–11472.
3. Borchert, G.M., Lanier, W., Davidson, B.L., RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 13 (2006), 1097–1101.
4. Cai, X., Hagedorn, C.H., Cullen, B.R., Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10 (2004), 1957–1966.
5. Chatzikyriakidou, A., Voulgari, P.V., Georgiou, I., et al. The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand J Immunol 71 (2010), 382–385.
6. Choi, H.R., Nam, K.M., Park, S.J., et al. Suppression of miR135b increases the proliferative potential of normal human keratinocytes. J Invest Dermatol 134 (2013), 1161–1164.
7. Chowdhari, S., Saini, N., Hsa-miR-4516 mediated downregulation of STAT3/CDK6/UBE2N plays a role in PUVA induced apoptosis in keratinocytes. J Cell Physiol 229 (2014), 1630–1638.
8. Devulapally, R., Sekar, N.M., Sekar, T.V., et al. Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy. ACS Nano 9 (2015), 2290–2302.
9. Esteller, M., Non-coding RNAs in human disease. Nat Rev Genet 12 (2011), 861–874.
10. Fleischmajer, R., Kuroda, K., Hazan, R., et al. Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2. J Invest Dermatol 115 (2000), 771–777.
11. Fu, D., Yu, W., Li, M., et al. MicroRNA-138 regulates the balance of Th1/Th2 via targeting RUNX3 in psoriasis. Immunol Lett 166 (2015), 55–62.
12. Garcia-Rodriguez, S., Arias-Santiago, S., Orgaz-Molina, J., et al. Abnormal levels of expression of plasma microRNA-33 in patients with psoriasis. Actas Dermosifiliogr 105 (2014), 497–503.
13. Glitzner, E., Korosec, A., Brunner, P.M., et al. Specific roles for dendritic cell subsets during initiation and progression of psoriasis. EMBO Mol Med 6 (2014), 1312–1327.
14. Gu, X., Nylander, E., Coates, P.J., et al. Effect of narrow-band ultraviolet B phototherapy on p63 and microRNA (miR-21 and miR-125b) expression in psoriatic epidermis. Acta Derm Venereol 91 (2011), 392–397.
15. Gudjonsson, J.E., Johnston, A., Dyson, M., et al. Mouse models of psoriasis. J Invest Dermatol 127 (2007), 1292–1308.
16. Guinea-Viniegra, J., Jimenez, M., Schonthaler, H.B., et al. Targeting miR-21 to treat psoriasis. Sci Transl Med, 6, 2014, 225re1.
17. Guo, S., Zhang, W., Wei, C., et al. Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity. Eur J Dermatol 23 (2013), 608–613.
18. Han, G., Williams, C.A., Salter, K., et al. A role for TGFbeta signaling in the pathogenesis of psoriasis. J Invest Dermatol 130 (2010), 371–377.
19. Han, J., Lee, Y., Yeom, K.H., et al. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18 (2004), 3016–3027.
20. Hickerson, R.P., Smith, F.J., Reeves, R.E., et al. Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. J Invest Dermatol 128 (2008), 594–605.
21. Hirao, H., Jinnin, M., Ichihara, A., et al. Detection of hair root miR-19a as a novel diagnostic marker for psoriasis. Eur J Dermatol 23 (2013), 807–811.
22. Ichihara, A., Jinnin, M., Oyama, R., et al. Increased serum levels of miR-1266 in patients with psoriasis vulgaris. Eur J Dermatol 22 (2012), 68–71.
23. Ichihara, A., Jinnin, M., Yamane, K., et al. microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris. Br J Dermatol 165 (2011), 1003–1010.
24. Janssen, H.L., Reesink, H.W., Lawitz, E.J., et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 368 (2013), 1685–1694.
25. Jinnin, M., Various applications of microRNAs in skin diseases. J Dermatol Sci 74 (2014), 3–8.
26. Johansen, C., Usher, P.A., Kjellerup, R.B., et al. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol 160 (2009), 319–324.
27. Joyce, C.E., Zhou, X., Xia, J., et al. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet 20 (2011), 4025–4040.
28. Koga, Y., Jinnin, M., Ichihara, A., et al. Analysis of expression pattern of serum microRNA levels in patients with psoriasis. J Dermatol Sci 74 (2014), 170–171.
29. Kryczek, I., Bruce, A.T., Gudjonsson, J.E., et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 181 (2008), 4733–4741.
30. Kulkarni, S., Qi, Y., O'HUigin, C., et al. Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc Natl Acad Sci USA 110 (2013), 20705–20710.
31. Kurd, S.K., Gelfand, J.M., The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 60 (2009), 218–224.
32. Lande, R., Botti, E., Jandus, C., et al. The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. Nat Commun, 5, 2014, 5621.
33. Landthaler, M., Yalcin, A., Tuschl, T., The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 14 (2004), 2162–2167.
34. Langrish, C.L., Chen, Y., Blumenschein, W.M., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005), 233–240.
35. Leachman, S.A., Hickerson, R.P., Schwartz, M.E., et al. First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 18 (2010), 442–446.
36. Lee, R.C., Feinbaum, R.L., Ambros, V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993), 843–854.
37. Lee, Y., Ahn, C., Han, J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425 (2003), 415–419.
38. Lee, Y., Kim, M., Han, J., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23 (2004), 4051–4060.
39. Lerman, G., Avivi, C., Mardoukh, C., et al. MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R. PloS One, 6, 2011, e20916.
40. Leuschner, P.J., Ameres, S.L., Kueng, S., et al. Cleavage of the siRNA passenger strand during RISC assembly in human cells. EMBO Rep 7 (2006), 314–320.
41. Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005), 15–20.
42. Liu, L.Z., Li, C., Chen, Q., et al. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PLoS One, 22, 2011, e19139.
43. Lovendorf, M.B., Mitsui, H., Zibert, J.R., et al. Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis. Exp Dermatol 24 (2015), 187–193.
44. Lovendorf, M.B., Zibert, J.R., Gyldenlove, M., et al. MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis. J Dermatol Sci 75 (2014), 133–139.
45. Lowes, M.A., Kikuchi, T., Fuentes-Duculan, J., et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128 (2008), 1207–1211.
46. Matranga, C., Tomari, Y., Shin, C., et al. Passenger-strand cleavage facilitates assembly of siRNA into AGO2-containing RNAi enzyme complexes. Cell 123 (2005), 607–620.
47. Maurano, M.T., Humbert, R., Rynes, E., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337 (2012), 1190–1195.
48. Meisgen, F., Xu Landen, N., Wang, A., et al. MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes. J Invest Dermatol 134 (2014), 1931–1940.
49. Meisgen, F., Xu, N., Wei, T., et al. MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis. Exp Dermatol 21 (2012), 312–314.
50. Nair, R.P., Duffin, K.C., Helms, C., et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41 (2009), 199–204.
51. Nair, R.P., Henseler, T., Jenisch, S., et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 6 (1997), 1349–1356.
52. Nair, R.P., Ruether, A., Stuart, P.E., et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 128 (2008), 1653–1661.
53. Nanney, L.B., Stoscheck, C.M., Magid, M., et al. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 86 (1986), 260–265.
54. O'Connell, R.M., Baltimore, D., MicroRNAs and hematopoietic cell development. Curr Top Dev Biol 99 (2012), 145–174.
55. O'Connell, R.M., Rao, D.S., Baltimore, D., microRNA regulation of inflammatory responses. Annu Rev Immunol 30 (2012), 295–312.
56. Peng, H., Kaplan, N., Hamanaka, R.B., et al. microRNA-31/factor-inhibiting hypoxia-inducible factor 1 nexus regulates keratinocyte differentiation. Proc Natl Acad Sci USA 109 (2012), 14030–14034.
57. Pivarcsi, A., Meisgen, F., Xu, N., et al. Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-alpha therapy. Br J Dermatol 169 (2013), 563–570.
58. Primo, M.N., Bak, R.O., Schibler, B., et al. Regulation of pro-inflammatory cytokines TNFalpha and IL24 by microRNA-203 in primary keratinocytes. Cytokine 60 (2012), 741–748.
59. Raaby, L., Langkilde, A., Kjellerup, R.B., et al. Changes in mRNA expression precede changes in microRNA expression in lesional psoriatic skin during treatment with adalimumab. Br J Dermatol 173 (2015), 436–447.
60. Roberts, J.C., Warren, R.B., Griffiths, C.E., et al. Expression of microRNA-184 in keratinocytes represses argonaute 2. J Cell Physiol 228 (2013), 2314–2323.
61. Russell, T.J., Schultes, L.M., Kuban, D.J., Histocompatibility (HL-A) antigens associated with psoriasis. N Engl J Med 287 (1972), 738–740.
62. Smith, F.J., Hickerson, R.P., Sayers, J.M., et al. Development of therapeutic siRNAs for pachyonychia congenita. J Invest Dermatol 128 (2008), 50–58.
63. Sonkoly, E., Wei, T., Janson, P.C., et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?. PloS One, 2, 2007, e610.
64. Sonkoly, E., Wei, T., Pavez Lorie, E., et al. Protein kinase C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes. J Invest Dermatol 130 (2010), 124–134.
65. Taganov, K.D., Boldin, M.P., Chang, K.J., et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103 (2006), 12481–12486.
66. Tiilikainen, A., Lassus, A., Karvonen, J., et al. Psoriasis and HLA-Cw6. Br J Dermatol 102 (1980), 179–184.
67. Tili, E., Michaille, J.J., Cimino, A., et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179 (2007), 5082–5089.
68. Tsoi, L.C., Spain, S.L., Knight, J., et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 44 (2012), 1341–1348.
69. Tsuru, Y., Jinnin, M., Ichihara, A., et al. miR-424 levels in hair shaft are increased in psoriatic patients. J Dermatol 41 (2014), 382–385.
70. van der Fits, L., Mourits, S., Voerman, J.S., et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182 (2009), 5836–5845.
71. Venter, J.C., Adams, M.D., Myers, E.W., et al. The sequence of the human genome. Science 291 (2001), 1304–1351.
72. Wei, T., Xu, N., Meisgen, F., et al. Interleukin-8 is regulated by miR-203 at the posttranscriptional level in primary human keratinocytes [e-pub ahead of print]. Eur J Dermatol, 2013, 10.1684/ejd.2013.1997.
73. Wu, L.S., Li, F.F., Sun, L.D., et al. A miRNA-492 binding-site polymorphism in BSG (basigin) confers risk to psoriasis in central south Chinese population. Hum Genet 130 (2011), 749–757.
74. Xia, P., Fang, X., Zhang, Z.H., et al. Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol Lett 148 (2012), 151–162.
75. Xu, N., Brodin, P., Wei, T., et al. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol 131 (2011), 1521–1529.
76. Xu, N., Meisgen, F., Butler, L.M., et al. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol 190 (2013), 678–688.
77. Yan, S., Xu, Z., Lou, F., et al. NF-kappaB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nat Commun, 6, 2015, 7652.
78. Yekta, S., Shih, I.H., Bartel, D.P., MicroRNA-directed cleavage of HOXB8 mRNA. Science 304 (2004), 594–596.
79. Yi, R., Poy, M.N., Stoffel, M., et al. A skin microRNA promotes differentiation by repressing ‘stemness’. Nature 452 (2008), 225–229.
80. Yi, X., Zhao, G., Zhang, H., et al. MITF-siRNA formulation is a safe and effective therapy for human melasma. Mol Ther 19 (2011), 362–371.
81. Yu, J., Ryan, D.G., Getsios, S., et al. MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Proc Natl Acad Sci USA 105 (2008), 19300–19305.
82. Zhang, W., Yi, X., Guo, S., et al. A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study. J Cell Mol Med 18 (2014), 2225–2234.
83. Zhao, H., Wang, J., Gao, L., et al. MiRNA-424 protects against permanent focal cerebral ischemia injury in mice involving suppressing microglia activation. Stroke 44 (2013), 1706–1713.
84. Zhao, M., Wang, L.T., Liang, G.P., et al. Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris. Clin Immunol 150 (2014), 22–30.
85. Zhang, D., Wang, J., Wang, Z., et al. miR-136 modulates TGF-beta1-induced proliferation arrest by targeting PPP2R2A in keratinocytes [e-pub ahead of print]. Biomed Res Int, 2015, 10.1155/2015/453518.
86. Zibert, J.R., Lovendorf, M.B., Litman, T., et al. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci 58 (2010), 177–185.